|
GMCL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.660800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.131720E-02 |
| Normal-vs-Stage2 |
8.855600E-03 |
| Normal-vs-Stage3 |
8.046500E-04 |
| Normal-vs-Stage4 |
1.632490E-02 |
| Stage1-vs-Stage2 |
4.621000E-01 |
| Stage1-vs-Stage3 |
2.078800E-01 |
| Stage1-vs-Stage4 |
6.742400E-01 |
| Stage2-vs-Stage3 |
8.656000E-01 |
| Stage2-vs-Stage4 |
7.961400E-01 |
| Stage3-vs-Stage4 |
6.234600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.255100E-03 |
| Normal-vs-AfricanAmerican |
4.671000E-01 |
| Normal-vs-Asian |
2.348100E-02 |
| Caucasian-vs-AfricanAmerican |
1.716220E-01 |
| Caucasian-vs-Asian |
8.653000E-01 |
| AfricanAmerican-vs-Asian |
2.794000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.567850E-04 |
| Normal-vs-Female |
1.072280E-02 |
| Male-vs-Female |
8.188000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.272000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.796560E-03 |
| Normal-vs-Age(61-80Yrs) |
7.041800E-04 |
| Normal-vs-Age(81-100Yrs) |
2.911500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.926380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.696300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.225600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.715000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.033200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.946200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.711800E-01 |
| Classical-VS-Follicular |
5.88080000000213E-05 |
| Classical-VS-Other |
2.040600E-01 |
| Classical-VS-Normal |
6.410300E-02 |
| Tall-VS-Follicular |
1.327440E-01 |
| Tall-VS-Other |
4.345000E-01 |
| Tall-VS-Normal |
1.561760E-02 |
| Follicular-VS-Other |
9.546000E-01 |
| Follicular-VS-Normal |
2.3685000000162E-06 |
| Other-VS-Normal |
3.888400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.750500E-04 |
| Normal-vs-N1 |
6.941200E-03 |
| N0-vs-N1 |
9.736200E-01 |
|
|
